Does AMPRENAVIR Cause Pancytopenia? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Pancytopenia have been filed in association with AMPRENAVIR. This represents 11.9% of all adverse event reports for AMPRENAVIR.
13
Reports of Pancytopenia with AMPRENAVIR
11.9%
of all AMPRENAVIR reports
0
Deaths
7
Hospitalizations
How Dangerous Is Pancytopenia From AMPRENAVIR?
Of the 13 reports, 7 (53.8%) required hospitalization.
Is Pancytopenia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMPRENAVIR. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does AMPRENAVIR Cause?
Virologic failure (36)
Viral mutation identified (34)
Drug resistance (24)
Pathogen resistance (24)
Treatment failure (24)
Drug ineffective (11)
Toxicity to various agents (11)
Dysuria (10)
Hiv infection (10)
Immunodeficiency (10)
What Other Drugs Cause Pancytopenia?
METHOTREXATE (5,377)
CYCLOPHOSPHAMIDE (3,351)
CARBOPLATIN (2,910)
RITUXIMAB (2,400)
LENALIDOMIDE (2,259)
DOXORUBICIN (2,212)
VINCRISTINE (2,180)
ETOPOSIDE (2,129)
DEXAMETHASONE (2,053)
PREDNISONE (1,743)
Which AMPRENAVIR Alternatives Have Lower Pancytopenia Risk?
AMPRENAVIR vs AMPYRA
AMPRENAVIR vs AMRUBICIN
AMPRENAVIR vs AMSACRINE
AMPRENAVIR vs ANAGRELIDE
AMPRENAVIR vs ANAKINRA